Genocea Biosciences, Inc. Gains 41.92%

Wed, Jun 15, 2022 at 09:41 PM
Genocea Biosciences, Inc. Gains 41.92%

Genocea Biosciences, Inc. (GNCA:NASDAQ) soared at $0.02, representing a gain of 41.9%. On Wed, Jun 15, 2022, GNCA:NASDAQ touched a New 2-Week Intraday Low of $0.01. The stock appeared on our News Catalysts scanner on Tue, May 24, 2022 at 01:23 PM in the 'INVESTOR UPDATE' category. From Wed, Jun 01, 2022, the stock recorded 0.00% Up Days and 10.00% Green Days

The stock spiked on Mon, Dec 27, 2021 at $1.48 with a volume of 7M+.

About Genocea Biosciences, Inc. (GNCA:NASDAQ)

Genocea Biosciences Inc is a biopharmaceutical company that discovers and develops novel vaccines and immunotherapies to address diseases with unmet needs. The Company's products include GEN-003 and GEN-004.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.